Sarcoma Section Chief
City of Hope, Department of Medical Oncology & Therapeutics Research
Dr. Mark Agulnik is Professor in the Department of Medical Oncology and Therapeutics Research, City of Hope and Section Chief of the Sarcoma Program. He serves as the Medical Director or the Clinical Trials Office at City of Hope Comprehensive Cancer Center. Dr. Agulnik is a member of the NCCN guidelines panel for Soft Tissue Sarcoma, GIST and Bone Sarcomas. His research currently focuses on novel therapeutics, immunotherapy trials, including combination approaches and novel cellular therapeutics, for patients with Sarcomas. He is a member of both ASCO’s Health Equity and Outcomes Committee and Sexual and Gender Minorities (SGM) Task Force. He also serves as a Member for ASCO’s In-Training Exam Task Force for ASCO’s Medical Oncology In-Training Examination.
